BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Muñoz AE, Pollarsky FD, Marino M, Cartier M, Vázquez H, Salgado P, Romero G. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy. World J Gastroenterol 2021; 27(28): 4639-4652 [PMID: 34366626 DOI: 10.3748/wjg.v27.i28.4639]
URL: https://www.wjgnet.com/1007-9327/full/v27/i28/4639.htm
Number Citing Articles
1
Mohan Chandra Vinay Bharadwaj Gudiwada, Vinuthna Gaddam, Maheen Rahman, Jaswanth R Jasti, Paritaben Bhalodia, Sahas Reddy Jitta. High-Intensity Statin Therapy and Associated Rhabdomyolysis in Chronic Liver Disease: A Case Report and Review of LiteratureCureus 2023;  doi: 10.7759/cureus.39150
2
Andrew S. Bell, Emma M. O’Connell, Falk W. Lohoff. Cholesterol2022; : 747 doi: 10.1016/B978-0-323-85857-1.00036-5
3
Spencer R Goble, Philippe Nyembo, Holly Rodin, George Konstantinides, Jesse Powell, Amanda J Noska. Statin Utilization Among Individuals Infected With Hepatitis C Virus: A Retrospective Cohort StudyCureus 2023;  doi: 10.7759/cureus.36049
4
文瑾 程. New Advances in the Treatment of Portal Hypertension and Its Complications in CirrhosisAdvances in Clinical Medicine 2022; 12(03): 2192 doi: 10.12677/ACM.2022.123316
5
John P. ONeill, Cathal S Clifford, Niamh P. Nolan, P. Aiden McCormick. Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosisIrish Journal of Medical Science (1971 -) 2023; 192(4): 1657 doi: 10.1007/s11845-022-03153-0
6
Carlos Sanz-Garcia, Yulia A. Nevzorova, Eduardo Martínez-Naves, Francisco Javier Cubero, Alejandro Hionides-Gutierrez, Jose Ramón Sañudo, Carlos Enrich, Carles Rentero, Pau Sancho-Bru, Ricardo U. Macías-Rodriguez, Astrid Ruiz-Margain, David Kershenobich-Stalnikowitz, Nestor R. Vargas, Alberto E. Muñoz, Helder I. Nakaya. Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver CirrhosisGastroenterología y Hepatología (English Edition) 2023; 46(4): 322 doi: 10.1016/j.gastre.2022.05.010
7
Irina Gîrleanu, Anca Trifan, Laura Huiban, Cristina Muzîca, Oana Cristina Petrea, Ana Maria Sîngeap, Camelia Cojocariu, Stefan Chiriac, Tudor Cuciureanu, Irina Iuliana Costache, Carol Stanciu. Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to InjuryLife 2022; 12(7): 1036 doi: 10.3390/life12071036
8
Carlos Sanz-Garcia, Yulia A. Nevzorova, Eduardo Martínez-Naves, Francisco Javier Cubero, Alejandro Hionides-Gutierrez, Jose Ramón Sañudo, Carlos Enrich, Carles Rentero, Pau Sancho-Bru, Ricardo U. Macías-Rodriguez, Astrid Ruiz-Margain, David Kershenobich-Stalnikowitz, Nestor R. Vargas, Alberto E. Muñoz, Helder I. Nakaya. Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver CirrhosisGastroenterología y Hepatología 2023; 46(4): 322 doi: 10.1016/j.gastrohep.2022.05.012